148.65USD+4.20%Mkt Cap: 10.30B USDP/E: 34.75Last update: 2026-06-01
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap10.30B USD
Enterprise Value10.58B USD
Revenue (TTM)2.90B USD
Gross Profit1.94B USD
Net Income (TTM)247.10M USD
Revenue/Share41.28 USD
Last Price148.65 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5.4K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)34.75
P/E (Forward)17.96
PEG1.10
EV/EBITDA17.57
EV/Revenue3.65
P/S3.46
P/B6.73
EPS (TTM)4.27
EPS (Forward)8.07
52W Range
140.634% of range354.88
52W High354.88 USD
52W Low140.63 USD
Profitability
Gross Margin71.63%
Oper. Margin16.03%
EBITDA Margin20.75%
Profit Margin9.12%
ROE16.31%
ROA7.75%
Growth
Revenue Growth33.90%
Earnings Growth159.00%
Cash Flow & Leverage
Operating CF569.30M USD
CapEx (TTM)219.40M USD
FCF Margin8.73%
FCF Yield2.46%
Net Debt533.60M USD
Net Debt/EBITDA0.89
Balance Sheet
Debt/Equity0.63
Current Ratio2.49
Quick Ratio1.49
Book Value/Sh21.53 USD
Cash/Share6.936 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)241.88 USD
Target Range165.00 USD – 360.00 USD
# Analysts24
Ownership
Shares Out.69.26M
Float69.00M
Insiders0.32%
Institutions105.30%
Short Interest
Short Ratio1.9d
Short % Float4.91%
Short % Out.4.35%
Shares Short3.01M
Short (prev mo.)2.70M
Technical
SMA 50185.00 (-19.6%)
SMA 200269.87 (-44.9%)
Beta1.20
S&P 52W Chg27.70%
Avg Vol (30d)1.51M
Avg Vol (10d)1.57M
Technical Indicators
RSI (14)30.1
MACD-10.9128
MACD Signal-11.6427
MACD Hist.+0.7299
BB Upper172.33 USD
BB Middle154.79 USD
BB Lower137.24 USD
BB Width22.67%
ATR (14)7.299 USD
Vol Ratio (20d)0.49x